DONOR Milk Act
Summary
The DONOR Milk Act (HR8964) is an early-stage bill that would classify pasteurized donor human milk as a food under the FD&C Act and impose annual FDA inspections on manufacturers. It authorizes no direct spending and has only 5 cosponsors, with no companion Senate bill. No publicly traded companies are directly affected at this stage.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR8964 is a regulatory bill with zero authorized spending and no direct impact on publicly traded companies.
- 2.The bill's early stage and lack of Senate companion make passage in the 119th Congress improbable.
- 3.Donor human milk processing is dominated by private companies; no public equity exposure exists.
Market Implications
No market implications for any publicly traded company. The donor human milk industry is privately held and not represented in the provided SEC data. Energy sector data provided is unrelated.
Full Analysis
- On May 21, 2026, Rep. DeLauro (D-CT) introduced HR8964, the DONOR Milk Act, which was referred to the House Committee on Energy and Commerce. The bill is in the earliest legislative stage with no hearings or markup scheduled. 2) The bill does not authorize or appropriate any funding. It amends the FD&C Act to define pasteurized donor human milk as a food, requires annual FDA inspections of manufacturers, and clarifies that donor milk processors are not exempt from food facility registration. There is no grant program, tax credit, or procurement mandate. 3) The primary entities affected are non-profit milk banks (e.g., Human Milk Banking Association of North America members) and for-profit donor milk processors. No publicly traded company has donor human milk as a material revenue segment. Medela (private) and Prolacta Bioscience (private) are the largest players. 4) No real market data for donor milk companies exists in the provided data. The energy sector data is irrelevant to this bill. 5) The bill must pass committee, then the House floor, then the Senate (no companion bill), then be signed by the President. Given the 119th Congress is in its second session and the bill has minimal cosponsor support, passage in this Congress is unlikely.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Constance C. McDaniel Medically Necessary Infant Formula and Donor Milk Act
To amend the Richard B. Russell National School Lunch Act to require the Secretary of Agriculture to make grants to eligible entities to acquire and install milk storage-related equipment for use in elementary schools and secondary schools, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.